Search company, investor...

Founded Year



Grant | Alive

Total Raised


Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+90 points in the past 30 days

About Biotwin

Biotwin develops an innovative technology to create digital twins for humans. It offers health professionals with data-driven and technological solutions to help them make better decisions and recommendations. Its software combines various health data with artificial intelligence to create personalized and comprehensive profiles, assisting patients to avail of healthcare facilities in time. The company was founded in 2018 and is based in Quebec City, Canada.

Headquarters Location

1405, boul. Du Parc Technologique 2nd floor

Quebec City, Quebec, G1P 4P5,




Latest Biotwin News

Government of Canada Invests in BioTwin to Fund Innovative Artificial Intelligence Technology

Nov 23, 2023

Life Sciences British Columbia All News November 17, 2023 LSBC Communications Canadian small and medium-sized businesses play a vital role in driving innovation and contributing to Canada’s vibrant research and development ecosystem. As more and more companies harness the power of artificial intelligence, the Government of Canada is delivering on its commitment to support the growth of Canadian businesses while helping to position Canada as a world leader in responsible artificial intelligence research and innovation. The Honourable Jean-Yves Duclos, Minister of Public Services and Procurement and Member of Parliament for Québec, on behalf of the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, celebrated the success of BioTwin  and announced that the company is receiving advisory services and up to $425,000 in funding through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). The funding will support the development of BioTwin’s virtual twin technology, which uses patients’ metabolomic profiles and artificial intelligence to detect and predict early cancer development to better assist health care professionals. Today’s announcement further demonstrates the Government of Canada’s commitment to supporting innovative Canadian businesses, helping them take their big ideas to the next level. By helping to revolutionize our health care industry, this contribution also aligns with Canada’s  Biomanufacturing and Life Sciences Strategy  and supports the growth of Canada’s life sciences ecosystem. Quotes “When we support Canada’s small and medium-sized businesses to help them take their innovative ideas to the next level, great things happen. By supporting BioTwin and other innovators like them, we are helping solve some of the biggest challenges Canadians face.” – The Honourable Jean-Yves Duclos, Minister of Public Services and Procurement and Member of Parliament for Québec “Artificial intelligence is one of the greatest technological advances of our generation and already has a significant impact on the daily lives of Canadians. Our government is committed to supporting Canadian companies developing responsible artificial intelligence technologies that allow them to tackle big challenges through innovative solutions, helping to shape a better future for all Canadians.” – The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry “NRC IRAP supports innovative Canadian small and medium-sized businesses in developing, commercializing and launching new technologies. Companies like BioTwin are making Canada’s research and technology landscape stronger and more innovative, and we are committed to providing them with the support they need to successfully grow and take these ideas to market.” – Iain Stewart, President, National Research Council of Canada “We are grateful for the continued support of the Government of Canada and energized by our shared vision that innovation and equitable access to early detection tools are the pillars that will tip the scales in our favor in the fight against cancer.” – Louis-Philippe Noel, General Manager and Co-Founder, BioTwin Quick facts The National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) provides advice, connections and funding to help Canadian small and medium-sized businesses increase their innovation capacity and take ideas to market. Through its network of over 265 industrial technology advisors in over 110 locations across Canada, NRC IRAP provides customized solutions to Canadian small and medium-sized businesses through expert advice, funding, and access to national and international networks across all industry sectors. In fiscal year 2022–23, NRC IRAP assisted more than 9,000 firms, funded over 3,000 projects and provided advisory services to more than 6,000 unfunded firms. On February 16, 2023, the Government of Canada released its  blueprint for the Canada Innovation Corporation , which will integrate NRC IRAP activities. The Canada Innovation Corporation will help drive Canadian business investment in research and development and foster economic growth. Contacts

Biotwin Frequently Asked Questions (FAQ)

  • When was Biotwin founded?

    Biotwin was founded in 2018.

  • Where is Biotwin's headquarters?

    Biotwin's headquarters is located at 1405, boul. Du Parc Technologique, Quebec City.

  • What is Biotwin's latest funding round?

    Biotwin's latest funding round is Grant.

  • How much did Biotwin raise?

    Biotwin raised a total of $6.96M.

  • Who are the investors of Biotwin?

    Investors of Biotwin include National Research Council Canada, Clinique Medfuture and Government of Canada.

  • Who are Biotwin's competitors?

    Competitors of Biotwin include Philips Lifeline and 6 more.


Compare Biotwin to Competitors

Rad AI Logo
Rad AI

Rad AI uses machine learning to automate repetitive tasks for radiologists. The company’s first product automatically generates the impression section of radiology reports, customized specifically to the preferred language of each radiologist. It was founded in 2018 and is based in Berkeley, California.

Clew Medical Logo
Clew Medical

Clew offers artificial intelligence (AI) analytics platforms. It provides an AI-based analytics service and mobile application for the early detection of life-threatening complications in patients in intensive care units. It was formerly known as Intensix. It was founded in 2014 and is based in Wilmington, Delaware.

Proscia Logo

Proscia focuses on the development of intelligent software. The company's main offerings include a digital pathology platform and artificial intelligence (AI) powered applications assisting in routine pathology operations, aiming to accelerate breakthroughs and improve patient outcomes. It primarily serves the life sciences and diagnostics sectors. It was founded in 2014 and is based in Philadelphia, Pennsylvania.

Freer Logic

Freer Logic offers business-to-business (B2B) neurotechnology for monitoring and training. The company develops body-based and non-contact neurotechnology products for athletes, professionals, attention deficit hyperactivity disorder (ADHD) children, and adults. It was founded in 2005 and is based in Fletcher, North Carolina.

TRIBVN Healthcare Logo
TRIBVN Healthcare

TRIBVN Healthcare is a company focused on the digital transformation of cancer diagnosis within the healthcare sector. The company offers innovative solutions for the management, analysis, and sharing of cellular images, leveraging artificial intelligence technologies to support diagnostic decision-making and scientific evaluation. Its primary customers include diagnostic laboratories, pharmaceutical companies, and biotech organizations. It was founded in 2011 and is based in Paris, France.


Pons is a company focused on digital health, specifically in the medical imaging sector. The company's main offering is an AI-driven mobile ultrasound technology that enables individuals with limited medical background to perform ultrasound imaging and monitor chronic disease progress outside of hospital settings. This technology is primarily targeted towards the healthcare industry. It was founded in 2019 and is based in Brooklyn, New York.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.